Challenges in conducting psychiatry studies in India
2011

Challenges in Conducting Psychiatry Studies in India

publication

Author Information

Author(s): Saifuddin Kharawala, Jeroze Dalal

Primary Institution: GlaxoSmithKline Pharmaceuticals India Ltd.

Conclusion

Conducting psychiatry studies in India presents unique challenges due to ethical issues, recruitment difficulties, and the complexities of informed consent.

Supporting Evidence

  • Ethical issues in psychiatry studies include risks to patients and the validity of informed consent.
  • There are only about 4,000 psychiatrists for 6.5 crore mentally ill patients in India.
  • The high placebo response complicates the assessment of treatment efficacy in psychiatry studies.

Takeaway

Studying mental health in India is hard because there are many rules and challenges that make it tough to find and help patients.

Potential Biases

Potential biases may arise from the high placebo response and the challenges in assessing consent capacity.

Limitations

The limited number of trained psychiatrists and strict eligibility criteria can hinder recruitment and study quality.

Participant Demographics

The study discusses a population of mentally ill patients in India, often accompanied by caregivers.

Digital Object Identifier (DOI)

10.4103/2229-3485.76284

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication